CerSci Therapeutics: Solebury Trout: CerSci Therapeutics Provides Clinical and Corporate Update
- Full data of Phase I single-ascending dose safety and tolerability study of CT-044 expected in mid-2020 - Teresa Byrne joins as Director of Clinical Operations DALLAS, TX / ACCESSWIRE / April 15,...
Read full article »
CerSci is a biopharmaceutical company that provides non-opioid analgesic products for the treatment of sciatica and neuropathic pain syndromes.
Read more